203 related articles for article (PubMed ID: 7021470)
21. Clinical comparison between glibornuride (Glutril) and tolbutamide in maturity-onset diabetes: a controlled double-blind trial.
Lindbjerg IF; Christoffersen EM; Kuusisto A; Lodahl K; Sagild U; Sterling N; Mikkelsen BO
Curr Ther Res Clin Exp; 1976 Sep; 20(3):277-82. PubMed ID: 134878
[No Abstract] [Full Text] [Related]
22. Control of blood sugar level in elderly diabetic patients.
Davis PJ; Davis FB
Prim Care; 1982 Mar; 9(1):45-51. PubMed ID: 7041153
[No Abstract] [Full Text] [Related]
23. Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.
Berchtold P; Björntorp P; Gustafson A; Jonsson A; Fagerberg SE
Eur J Clin Pharmacol; 1971 Dec; 4(1):22-8. PubMed ID: 5151389
[No Abstract] [Full Text] [Related]
24. Diabetes mellitus--practical aspects: serial determination of plasma insulin levels is useful method of determining type of diabetes.
D'Allessandro FM
R I Med J (1976); 1982 Jun; 65(6):247-50. PubMed ID: 7051252
[No Abstract] [Full Text] [Related]
25. Blood coagulation in maturity--onset diabetics before and after treatment with glibenclamide.
Bunnag SC; Israsena T; Watananukul P
J Med Assoc Thai; 1972 Feb; 55(2):80-6. PubMed ID: 4622655
[No Abstract] [Full Text] [Related]
26. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy.
Greenfield MS; Doberne L; Rosenthal M; Vreman HJ; Reaven GM
Arch Intern Med; 1982 Aug; 142(8):1498-1500. PubMed ID: 7103631
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of diabetes mellitus].
Baranov VG; Orkodashvili LSh
Klin Med (Mosk); 1973 Jul; 51(7):129-36. PubMed ID: 4786254
[No Abstract] [Full Text] [Related]
28. [Monitoring of blood sugar levels during insulin treatment of diabetes mellitus].
Chen JW
Zhonghua Yi Xue Za Zhi; 1984 Mar; 64(3):184-6. PubMed ID: 6432274
[No Abstract] [Full Text] [Related]
29. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
Herrlinger H; Dörfler H; Wolfram G; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
[No Abstract] [Full Text] [Related]
30. Update on diabetes mellitus.
Moss JM
Med Times; 1981 Aug; 109(8):70-3. PubMed ID: 7024704
[No Abstract] [Full Text] [Related]
31. Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea.
Klupa T; Skupien J; Mirkiewicz-Sieradzka B; Gach A; Noczynska A; Szalecki M; Kozek E; Sieradzki J; Mlynarski W; Malecki MT
Diabet Med; 2009 Jun; 26(6):663-4. PubMed ID: 19538247
[No Abstract] [Full Text] [Related]
32. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
[No Abstract] [Full Text] [Related]
33. [Self-determination of blood glucose in insulin-dependent diabetes mellitus].
Andersen AR; Andersen JK; Svendsen PA; Frost-Larsen K; Christiansen JS; Deckert T
Ugeskr Laeger; 1980 Aug; 142(32):2038-42. PubMed ID: 6996263
[No Abstract] [Full Text] [Related]
34. Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
Sachse G; Willms B
Diabetologia; 1979 Nov; 17(5):287-90. PubMed ID: 387504
[No Abstract] [Full Text] [Related]
35. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.
Kosaka K; Kuzuya T; Akanuma Y; Hagura R
Diabetologia; 1980 Jan; 18(1):23-8. PubMed ID: 6988263
[TBL] [Abstract][Full Text] [Related]
36. UK prospective study of therapies of maturity-onset diabetes. I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year.
Diabetologia; 1983 Jun; 24(6):404-11. PubMed ID: 6350078
[No Abstract] [Full Text] [Related]
37. [Metabolic and hormonal response to a standardized breakfast in type 2 diabetes. Effect of glipizide].
Scheen AJ; de la Torre D; Luyckx AS; Lefèbvre PJ
Rev Med Liege; 1983 Mar; 38(6):189-98. PubMed ID: 6344171
[No Abstract] [Full Text] [Related]
38. A clinical trial of glibornuride in maturity-onset diabetes mellitus.
Tandhanand S; Vannasaeng S; Aswapokee N; Soongsavang V; Aphonsuvan S
J Med Assoc Thai; 1974 May; 57(5):232-6. PubMed ID: 4832761
[No Abstract] [Full Text] [Related]
39. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
[TBL] [Abstract][Full Text] [Related]
40. Glucose lowering treatment in patients with coronary artery disease is prognostically important not only in established but also in newly detected diabetes mellitus: a report from the Euro Heart Survey on Diabetes and the Heart.
Anselmino M; Ohrvik J; Malmberg K; Standl E; Rydén L;
Eur Heart J; 2008 Jan; 29(2):177-84. PubMed ID: 18156611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
